# WD-1603 PK Study in Healthy Volunteers

> **NCT03761004** · PHASE1 · COMPLETED · sponsor: **Hong Kong WD Pharmaceutical Co., Limited** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** carbidopa-levodopa

## Key facts

- **NCT ID:** NCT03761004
- **Lead sponsor:** Hong Kong WD Pharmaceutical Co., Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-14
- **Primary completion:** 2019-09-05
- **Final completion:** 2019-09-05
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2020-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03761004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03761004, "WD-1603 PK Study in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03761004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*